Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Practical steps for implementing a scalable NCD programme Lessons from Abu Dhabi
Health Policy Roundtable, Xi’an, PRC
11:15-11:30, 25 May 2012
Success…
1
Opportunity Plan Results Sustainable results
Opportunity
Situation 2006
•Full range of services for diverse population (2 cities + rural)
•2.4m population
•No/poor data •Outcomes poor relative to spend •Political will to improve
outcomes and quality
•Adequate financial resources
Implication
•Prototype health system •Small enough to make rapid difference
•Improving data should allow quick wins
•Opportunity to shift quality/ outcomes
from low base
•Window of opportunity to focus on outcomes
Impact, transferable
2
Source Health Statistics Analysis
Plan how we got started in Abu Dhabi
(IR-)DRGs fully implemented
in one year (2011)
3
Plan overall data standard is HL7 v3
4
“Smart” HL7 v3 • RIM • XML
Source Health statistics
ID GrossPremium Package Start/Renewal Expiry PolicyHolder Relation
IDs Gross PatientShare Net PaymentAmount
Person
Provider Payer Claim
Financing Encounter
FirstName ContactNumber PassportNumber BirthDate Gender Nationality City
IDs Start StartType Type End EndType Diagnoses
Activity Type Code Quantity Net Clinician
Observation
5
Plan Abu Dhabi data model
Source Health statistics 6
Plan Abu Dhabi data model
Identifiers (Facility, Professional, Patient)
Diagnoses (ICD-9CM, principal/secondary, presenting/discharge)
Activity (CPT-4, ACT(plus) – drug and dose, medical devices)
Observation (LOINC – including mandatory fields, e.g., HbA1c)
Outcomes (discrete)
Plan Full data dictionary and tech specs available at www.shafafiya.org
7
•Dictionary
•Codes
• Standards (15 pages only)
•Governance
• Schemas (4 transactions)
•Prices
Results setup today Simplified
8
Web service Shafafiya.org
(Enterprise service bus)
Licensed Providers
Licensed Providers
Licensed Providers
Licensed Providers
Licensed Providers [n = 1,367]
Licensed Providers
Licensed Providers
Licensed Providers
Licensed Providers
Licensed Payers [n = 38]
KEH
Regulator data warehouse
BI system OLAP cubes
Excel Pivot table
Results selected highlights
9
1. Node centrality of Shafafiya means the Abu Dhabi eHealth system is highly adaptable, e.g., ePrescribing, Electronic Health Records
2. Web-based solution so massively scalable (e.g., 100x volume increase 2011-2012)
3. All Abu Dhabi health data captured on KEH (pharmacy, primary, secondary, tertiary, government and private, citizens and expatriates)
4. >99,99% service uptime (2011)
5. >1 million transactions per day (2012)
6. Initial batch-processes (eClaims and remittances)
7. Now real-time processing of five transaction types (e.g., “PriorAuthorisation” used for eEligibility, eAuthorisation, ePrescribing, ePBM)
8. Migrated to (IR-)DRGs 2011-12
9. Data protection hardwired into systems (“IT as Policy”)
10. Very active Data Standards Panel
11. Data Access Panel
12. Full Data Standards and Architecture open-source [www.shafafiya.org]
Results achieving universal health insurance 2006-2008
Note Some member numbers may be inflated, as in-year cancellations are not excluded
Source Abu Dhabi Payer submissions; Some insurance data not available (AXA, and Al Wathba, Noor Takaful Family, Dubai, Green Crescent, Al Hilal Takaful – PJSC and Methaq Takaful
10
Results data has changed everything… Leading causes of death 2010
Note Causes of death classified according to WHO ICD-10, 2009 data had been revised by the Public Health
Source Death notification data - Emirate of Abu Dhabi, 2010, HAAD-Public Health and Policy
Injury, poisoning and certain
other consequences of external causes
1%
Congenital malformations,
deformations and chromosomal abnormalities
5%Endocrine,
nutritional and metabolic diseases
7%
External causes of morbidity and
mortality19%Neoplasms
16%
Other causes25%
Diseases of the circulatory system
27%
Causes 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Diseases of the circulatory system 763 707 697 506 378 424 413 624 778 622
External causes of morbidity and mortality 546 632 464
Injury, poisoning and certain
other consequences of external causes42 57 85
Neoplasms 465 397 360 370 315 294 298 276 289 252
Endocrine, nutritional and metabolic diseases 194 210 79 201 130 133 126 103 73 65
Congenital malformations, deformations and
chromosomal abnormalities142 199 120 177 131 156 146 152 199 190
Other 727 715 1'144 867 993 874 943 763 664 845
Total 2'879 2'917 2'949 2'742 2'450 2'446 2'489 2'492 2'617 2'574
600621 503 565 563 574 614
11
Encounters by diagnosis group, % of volume
Note Non-disease conditions include Injuries (ICD-9 codes 800-999)
Source Health Statistics analysis; Cube 2010; categorization based on WHO classification of ICD diagnoses 12
Total Outpatient ER Inpatient
% of Total Encounters 100 92.2 6.3 1.5
Non-disease conditions 21.5 20.3 38.4 24.3
Respiratory infections 14.8 15.0 13.9 4.8
Musculoskeletal diseases 8.2 8.4 6.6 2.6
Digestive diseases 6.5 6.5 6.6 8.3
Endocrine disorders 5.6 5.9 1.5 5.9
Cardiovascular diseases 5.6 5.8 3.1 6.7
Respiratory diseases 5.4 5.4 5.4 5.2
Skin diseases 4.9 5.1 2.6 1.8
Genitourinary diseases 4.7 4.7 3.6 6.5
Diabetes mellitus 4.6 4.8 2.1 3.7
Sense organ diseases 3.9 4.1 2.2 2.9
Oral conditions 3.5 3.7 0.8 0.5
Infectious and parasitic diseases 3.4 3.5 2.3 3.3
Neuropsychiatric conditions 2.1 2.1 1.8 2.7
Nutritional deficiencies 2.0 2.2 0.3 1.9
Maternal and Perinatal conditions 2.0 1.7 2.4 13.0
Cancer 0.6 0.6 0.2 2.9
Injuries 0.5 5.4 1.4
Congenital anomalies 0.3 0.2 1.2
RTA 0.06 0.6 0.4
100 100 100
Results hospital inpatient profile by value
* Share of top 5 Diagnoses groups within providers
Note Non-disease conditions includes injury codes (800-799)
Source Health Statistics analysis; Cube 2010; categorization based on WHO classification of ICD diagnoses 13
Hospital Name Overall Top 5* 1st 2nd 3rd 4th 5th
Tawam 24 Maternal and Perinatal conditions (24%) Non-disease conditions (24%) Cardiovascular diseases (9%) Cancer (9%) Endocrine disorders (5%)
SKMC 9 Cardiovascular diseases (16%) Non-disease conditions (16%) Congenital anomalies (12%) Musculoskeletal diseases (9%) Neuropsychiatric conditions (7%)
Al Noor - Airport Road 8 Cardiovascular diseases (26%) Maternal and Perinatal conditions (21%) Digestive diseases (11%) Respiratory diseases (9%) Non-disease conditions (7%)
Al Corniche 7 Maternal and Perinatal conditions (82%) Non-disease conditions (15%) Genitourinary diseases (2%) Cancer (1%) Infectious and parasitic diseases (%)
Al Ain 6 Maternal and Perinatal conditions Non-disease conditions (14%) Digestive diseases (11%) Neuropsychiatric conditions (9%) Respiratory diseases (7%)
Al Noor 6 Maternal and Perinatal conditions (21%) Digestive diseases (14%) Non-disease conditions (12%) Respiratory diseases (11%) Genitourinary diseases (10%)
Al Mafraq 5 Non-disease conditions (24%) Maternal and Perinatal conditions (18%) Cardiovascular diseases (11%) Sense organ diseases (8%) Digestive diseases (7%)
N M C Specialty 5 Cardiovascular diseases (19%) Digestive diseases (17%) Non-disease conditions (12%) Musculoskeletal diseases (11%) Maternal and Perinatal conditions (10%)
Oasis 4 Maternal and Perinatal conditions (75%) Digestive diseases (6%) Non-disease conditions (6%) Genitourinary diseases (4%) Respiratory infections (3%)
Al Noor - Al Ain 3 Maternal and Perinatal conditions (17%) Digestive diseases (17%) Non-disease conditions (13%) Cardiovascular diseases (12%) Genitourinary diseases (12%)
Madinat Zayed 3 Maternal and Perinatal conditions (25%) Non-disease conditions (17%) Digestive diseases (16%) Cardiovascular diseases (10%) Respiratory infections (8%)
Al Salama 3 Non-disease conditions (33%) Digestive diseases (17%) Respiratory diseases (10%) Musculoskeletal diseases (8%) Respiratory infections (7%)
Life Line 2 Non-disease conditions (20%) Maternal and Perinatal conditions (18%) Digestive diseases (14%) Genitourinary diseases (12%) Musculoskeletal diseases (8%)
Al Ahlia 2 Cardiovascular diseases (27%) Digestive diseases (21%) Genitourinary diseases (16%) Non-disease conditions (11%) Maternal and Perinatal conditions (7%)
Al Rahba 2 Respiratory diseases (45%) Maternal and Perinatal conditions (35%) Digestive diseases (5%) Musculoskeletal diseases (4%) Genitourinary diseases (2%)
N M C Specialty - Al Ain 2 Digestive diseases (2%) Musculoskeletal diseases (2%) Non-disease conditions (2%) Genitourinary diseases (2%) Cardiovascular diseases (1%)
Behavioral Sciences Pavilion 1 Digestive diseases (99%) Musculoskeletal diseases (1%) Non-disease conditions (%) Genitourinary diseases (%) Cardiovascular diseases (%)
Emirates French 1 Respiratory diseases (65%) Maternal and Perinatal conditions (12%) Digestive diseases (5%) Cancer (4%) Non-disease conditions (4%)
Emirates International 1 Digestive diseases (24%) Non-disease conditions (16%) Maternal and Perinatal conditions (15%) Cardiovascular diseases (9%) Respiratory diseases (8%)
Gulf Diagnostic Center 1 Respiratory diseases (32%) Genitourinary diseases (17%) Respiratory infections (9%) Digestive diseases (8%) Cardiovascular diseases (6%)
Ghiathy 1 Respiratory infections (24%) Maternal and Perinatal conditions (23%) Digestive diseases (11%) Non-disease conditions (11%) Cardiovascular diseases (9%)
Dar Al Shifaa 1 Respiratory diseases (23%) Digestive diseases (17%) Maternal and Perinatal conditions (14%) Genitourinary diseases (11%) Respiratory infections (8%)
Specialized Medical Care 1 Genitourinary diseases (26%) Respiratory diseases (25%) Maternal and Perinatal conditions (13%) Digestive diseases (8%) Infectious and parasitic diseases (8%)
Marfa Hospital 1 Maternal and Perinatal conditions (41%) Non-disease conditions (16%) Digestive diseases (9%) Respiratory infections (9%) Cardiovascular diseases (6%)
Ruwais 1 Maternal and Perinatal conditions (54%) Digestive diseases (13%) Non-disease conditions (12%) Cardiovascular diseases (6%) Respiratory infections (5%)
Silla 1 Maternal and Perinatal conditions (38%) Cardiovascular diseases (13%) Digestive diseases (12%) Respiratory infections (11%) Non-disease conditions (10%)
Delma 0 Maternal and Perinatal conditions (30%) Digestive diseases (20%) Non-disease conditions (12%) Respiratory infections (9%) Skin diseases (7%)
Al Reef Internaional 0 Musculoskeletal diseases (82%) Genitourinary diseases (6%) Non-disease conditions (5%) Cardiovascular diseases (2%) Digestive diseases (1%)
National 0 Digestive diseases (34%) Genitourinary diseases (12%) Cardiovascular diseases (10%) Respiratory infections (9%) Non-disease conditions (8%)
Results labour productivity
Note Productivity is defined as adjusted episodes per clinician per day. An Episode is any encounter with a consultation. To account for the higher resource need of inpatients, inpatient episodes are multiplied by ratio of the average value (ClaimNet) of an Inpatient Episode versus an Outpatient episode. To reflect clinical complexity inpatient episodes are then adjusted by the difference of case mix index of each individual hospital from Abu Dhabi average. Seha hospitals episodes are underestimated due to certain Seha clinical obligations such as public events medical preparation. Tawam hospital provides rotating staff to Al Wagan which effects both hospitals’ productivity.
Source Cube 2010; HAAD licensing database; Operations Center data for 2009; Health Statistics analysis, Medical Group Management Association Survey
Indicative
14
Productivity Episodes (000)
Hospital Do
cto
r
Nu
rse
Inp
atie
nt
Ou
tpat
ien
t
Tota
l,
We
igh
ted
Al Ahalia 12.0 14.2 3.4 350.3 402.9
Al Wagan 10.9 3.2 .6 38.7 47.6
Oasis 10.1 4.0 6.0 105.7 188.8
Al Noor 9.4 6.8 8.5 414.0 533.3
Al Salama 9.3 7.1 2.8 154.1 190.9
Al Noor - Airport Road 9.1 5.2 7.0 294.7 408.6
Al Noor - Al Ain 8.9 5.3 4.8 261.1 327.2
Specialized Medical Care 8.6 11.2 1.2 56.1 69.3
Dar Al Shifaa 8.6 7.7 1.0 98.9 110.1
Al Ain 8.6 2.1 12.6 377.7 579.8
SKMC 8.0 2.3 17.7 580.3 1,021.3
National 7.7 4.5 .3 55.8 59.1
Emirates International 7.1 12.6 1.7 91.7 110.7
Life Line 6.6 5.1 2.7 151.6 189.4
Ghayathi 6.5 2.9 .8 40.8 52.0
N M C Specialty - Al Ain 6.4 3.1 1.6 122.8 147.4
Al Rahba 6.4 2.1 7.7 132.5 247.8
Gulf Diagnostic Center 6.3 8.0 .9 140.7 152.2
Delma 6.2 3.0 .3 20.8 24.9
N M C Specialty 5.9 3.1 4.4 238.8 310.1
Tawam 5.7 2.1 23.7 492.8 932.3
Al Corniche 5.7 1.6 12.3 76.7 257.8
Al Raha 5.6 8.2 .4 34.9 39.1
Al Sil la 5.2 2.1 .5 24.8 30.5
Al Mafraq 5.2 2.3 18.8 329.2 664.7
Al Mirfa 4.5 1.6 .4 24.5 29.4
Madinat Zayed 4.3 2.1 3.4 111.6 160.0
Emirates French 4.2 4.2 .9 28.4 41.2
Al Reef Internaional 4.0 3.0 .1 21.4 23.1
Al Rewaise 1.6 0.8 .3 10.8 14.6
Total/Average 6.4 2.9 146.7 4,882.1 7,366.3
Tawam
Al Mafraq
SKMC
Al Ain
Al Corniche
Al Rahba
Madinat Zayed
Ghayathi
Al Mirfa
Al Silla
Al Wagan
Delma
Al Noor
Oasis
N M C Specialty
Al Noor - Al Ain
Al Ahalia
Al Noor - Airport Road Al Salama
Life Line
Dar Al Shifaa
Emirates International
Emirates FrenchAl Reef Internaional
Gulf Diagnostic Center
Al Raha
Specialized Medical Care
N M C Specialty - Al Ain
National
Al Rewaise
Seha
Other
Epis
od
es
pe
r d
oct
or
pe
r d
ay
Episodes per nurse per day
6.4
2.9
Notes Diabetics is number of members who had an encounter with diagnosis of diabetes. Well controlled diabetes is a measure of diabetics whose latest HbA1c<7%. Moderate and well controlled diabetics is those whose latest HbA1c<7.5%.Poorly controlled diabetics is those whose latest HbA1c>9%. Related care indicators apply to diabetics only and indicate ≥1 test per member per annum. Rates shown are rates within breakdown category. Indicator definitions are available at https://www.shafafiya.org
Source KEH Episodes with Encounter start date 1 January – 31 December 2011 as at 21 February 2012 15
Results quality data is improving continuously
General
Diabetes
Results Abu Dhabi health system financing
16 Source HAAD external consultants
Financial Flows2010 Policy All Scenario
AED millions 1 Demand
Individuals
416.5
6.1 2,491.9
Insurance Thiqa
2,681.0 + 2,491.9
1,512.0 2.9
235.6 340.0
151.0 259.1 0.3
Thiqa Admin HAAD
235.6 340.0
Status Quo
Public providers
6,961.2
9,275.7
5,298.2
DoFEmployers
2,674.8
2,215.3
2,674.8
913.22,474.4
910.0
Private providers Foreign providers
High
Source Health Statistics Analysis
We planned sustainability from the start
Regulator • Transform regulatory ‘operations’
• Shift information asymmetry
• Cut admin staff and consumables
• Free 2.5 hours/day doctors time
• Automate and outsource claims
• Outgrow competition
Provider
Payer
Free software adds momentum
17
Outline of Weqaya Programme
The Approach Screen >90% adult Emiratis screened (>190,000) Plan Clinical Standards, website/call centre Act Clinical care, targeted lifestyle behaviour change (diet, physical exercise, tobacco) Levels of Intervention Population Nutrition (trans-fats, food labeling)
Physical activity (gyms, AD UPC) Tobacco control
Group Workplace
Schools Communities Families
Individual Clinical care
Encourage: Weqaya reports Enable: Website/call centre
Internet Mobile network
Aged Care Facilities
Community Service &
In Home Patient Care
Integration with Hospital Services
Long Term Illness & Care
Field Health
Services
NGN – MPLS Cloud
Insurance Co’s
Connecting through “the cloud”
Health impact to date Impact of Weqaya screening and follow-up on diabetes control
* Engagement with care defined as one or more HbA1c tests during period
Source KEH; Data cubes analysis
Key points
• One early indicator of impact is diabetes control (% HbA1c)
• National diabetic patients passing through Weqaya (C1) have substantially better control of diabetes than those not passing through Weqaya (C2/C3)
• Consistency of care is also far higher between facilities for diabetes than for management of other chronic disease
20
Our shared challenge…
Hannibal of Carthage, military commander
21
I know half my spending on advertising is wasted…
…the problem is I don’t know
which half
© Health Authority – Abu Dhabi (2010)
State Transition Matrix: Male, Age 66
22 Source Verisk, Strategy analysis
HCC1 HCC185
HCC
185
Probability = 0
Probability = 0.4
© Health Authority – Abu Dhabi (2010)
Treatment patterns
23
Co
nd
itio
n
Treatment
Relative Frequency
Hi Lo
Current status
Hannibal of Carthage, military commander
24
• Shafafiya and KEH data dictionary and source code available on Shafafiya.org
• Discussions ongoing regarding replication of key elements of Abu Dhabi model in 1. Dubai 2. Other UAE Emirates 3. Turkey 4. Seven SE Asian countries 5. Five African countries 6. UK (pilot, Birmingham)
Our philosophy
Hannibal of Carthage, military commander
25
If you want to go fast, go alone
If you want to go far, go together…
• Strong interest in Abu Dhabi in sharing data with others for data portability, performance benchmarking, shared learning, and shared innovation (particularly in tackling non-communicable diseases)
• Happy to provide support, particularly where there is potential for transnational sharing of data and innovation
Practical steps for implementing a scalable NCD programme Lessons from Abu Dhabi
Health Policy Roundtable, Xi’an, PRC
11:15-11:30, 25 May 2012
Source Gaps: 2011 survey of 575 clinicians; 2012 Interviews with Medical Directors; Planning analysis; Episodes: KEH; Physicians and Facilities: Licensing database; Waiting times: 2011 TPA analysis Note Growth compares 2009 to 2010
Results live capacity map As at 31 January 2012
C9
Capacity Balance
Critical capacity gap
Severe capacity gap
No capacity gap
% private/public capacity
Growth - public private
Growth - public
Waiting times
High
Intermediate
Low
Shorter than 2010
Longer than 2010
Specialty Gaps Physicians % P
riva
te
Growth Facilities % P
riva
te
Growth
Intensive & Critical care medicine 38 -1 9 2
Emergency medicine 90 -27 16 1 5-10 n/a
Neonatology 13 -5 7 30 1
Cardiology 71 -9 22 5 60 1
Psychiatry 49 18 16 3 60 1
Obstetrics & Gynecology 262 40 82 15 30-60 2
Pediatrics 369 61 87 3 5-10 1
Oncology 32 9 -2 60 2
General surgery 235 45 66 10 20-30 1
Pediatric surgery 17 -5 9 1 60 2
Internal Medicine 350 156 86 22
Physical medicine & Rehabilitation 16 2 13 2 n/a 1
Allergy & Immunology 3 1 3 1 60 1
Cardio-thoracic surgery 23 -1 11 1
Orthopedics 137 17 48 11 30 1
Family medicine 129 22 41 7 20-30 2
Radiology 145 30 55 9 30-60 1
Neurology 43 -3 18 1 60 2
Anesthesiology 226 49 38 4
Preventive medicine 2 1 n/a n/a
Ophthalmology 124 18 54 2 30 2
Infectious diseases 7 -5 6 -2
Dentistry 805 87 324 19 60-120 2-3
Urology 77 7 36 3 30-60 1
General medicine 1814 328 260 28 30-60 N/A
Pulmonology 14 -3 11 30-60 1
Pathology 146 34 79 12
Nephrology 22 -10 9 -3 60 1-2
Endocrinology 30 -2 11 -2 60 2
Dermatology 139 18 84 11 20-30 1
Gastroenterology 22 -7 12 -2 30 2-3
Alternative therapies 2 2 10-20 1
Oral & Maxillofacial surgery 48 3 39 3 60 2
Rheumatology 12 -3 11 1 60 2
Otolaryngology (ENT) 135 20 59 8 30 2
Total 5,647 875 1634 174
Walk-in (minutes)
Appointment(days)
Gaps
Source Population: SCAD, 2010 Estimate, UPC 2030 plans. Clinicians and Facilities: Licensing database. Planned Facilities ; SEHA, UPC 2030 plans, HAAD Planning analysis. C11
Population Facilities Clinicians Ratios 2030 Plan growth Hospitals Clinics
Region District Gap now Type Tota
l
% N
atio
nal
Nat
ion
als
Tota
l
Ho
spit
als
Cli
nic
s &
Ce
ntr
es
Ne
arb
y
ho
spit
al
Do
cto
rs
Nu
rse
s
De
nti
sts
Oth
er
Fac
ilit
ies
/10
00
0
Do
cto
rs
/10
00
Nu
rse
s
/10
00
Population Growth
ne
ed
un
de
r w
ay
ne
ed
un
de
r w
ay
Am
bu
lan
ce
sta
tio
n
20
30
Po
pu
lati
on
Abu Dhabi Desert Villages Rural 35,489 #NAME? 7,844 None 74,511 1 1L 1 110,000
Al Falah Rural 5,019 #NAME? 1,109 None 94,981 1 1M 1 1 100,000
Ghantoot District Rural 3,088 #NAME? 682 None 96,912 1 1M 1 100,000
Abu Dhabi Island Urban 391,040 #NAME? 86,429 229 13 182 2,529 3,878 430 1,284 5.0 6.5 9.9 33,960 425,000
CBD/Financial Centre Urban 217,602 #NAME? 48,095 124 5 86 1,131 1,663 241 539 4.2 5.2 7.6 (27,602) 1M 190,000
Musaffah Urban 176,035 #NAME? 38,908 36 31 161 194 21 68 1.8 0.9 1.1 (76,035) 3 100,000
Bani Yas Rural 58,872 #NAME? 13,012 43 37 162 106 57 73 6.3 2.8 1.8 11,128 4 1M 1 70,000
Al Shahama Rural 47,142 #NAME? 10,419 10 10 45 47 14 24 2.1 1.0 1.0 62,858 1 1 1 110,000
Shamkhah Rural 19,737 #NAME? 4,362 None 1 110,263 1 1 1 130,000
Al Rahba Rural 19,084 #NAME? 4,218 1 1 132 325 5 89 0.5 6.9 17.0 90,916 1 110,000
New Port City Rural 14,629 #NAME? 3,233 None 1 135,371 1 1L 1 150,000
Capital District South Urban 11,523 #NAME? 2,547 None 1 43,477 1 1L 1 55,000
Bain Al Jesrain Urban 9,588 #NAME? 2,119 3 3 33 42 10 17 3.1 3.4 4.4 15,412 1 1M 1 25,000
Khalifa City A Urban 6,626 #NAME? 1,464 11 1 10 78 74 17 75 16.6 11.8 11.2 63,374 1 6 1 70,000
Grand Mosque District Urban 6,551 #NAME? 1,448 None 1 113,449 1 1 1M 120,000
Inner Islands Urban 3,494 #NAME? 772 1 2 4 2.9 0.6 1.1 16,506 1M 1 20,000
Capital District North Urban 2,955 #NAME? 653 2 1 1 426 792 36 302 6.8 144.2 268.1 67,045 1 3 70,000
Al Mina Urban 1,333 #NAME? 295 7 4 87 103 25 62 30.0 65.2 77.2 98,667 1L 100,000
Al Raha Urban 1,031 #NAME? 228 2 1 1 41 42 9 12 19.4 39.8 40.8 118,969 1 1L 1 120,000
Yas Island Urban 967 #NAME? 214 None 99,033 1l 1 100,000
Mohamed Bin Zayed City Urban 409 #NAME? 90 2 2 1 2 4 2 2.4 4.9 49,591 4 1L 1 1 50,000
Saadiyat Urban 152 #NAME? 34 None 119,848 2L 1 120,000
Airport District Urban 122 #NAME? 27 6 4 8 11 5 11 65.5 90.1 49,878 1L 1 50,000
Lulu Island Urban 93 #NAME? 21 None 19,907 1M 1 20,000
Capital District Urban - #NAME? - None 240,000 2 1L 1 240,000
Mohamed Bin Zayed Centre Urban - #NAME? - None 80,000 1 80,000
South Hudayriat Island Rural - #NAME? - None 100,000 1 1L 100,000
Marina Village Urban - #NAME? - 3 2 1 3 6 5,000 1S 5,000
Al Suwwah Urban - #NAME? - None 30,000 1 1 30,000
Al Reem Urban - #NAME? - None 200,000 2L 1 200,000
Al Ain Umm Ghaffa Rural 9,250 #NAME? 2,884 None 2,650 1S 1 11,900
Nahel Rural 5,430 #NAME? 1,693 None 4,570 1S 1 10,000
Industrial City Rural 51,004 #NAME? 15,899 8 5 14 5 1 5 1.0 0.3 0.1 28,736 1 79,740
Al Salamat/Al Yaher Urban 39,237 #NAME? 12,231 1 1 1 3 1 6 0.3 0.1 0.0 34,763 1 1 1 1 74,000
Al Dhahra Rural 5,182 #NAME? 1,615 None 818 1S 6,000
Abu Krayyah Rural 4,293 #NAME? 1,338 None 707 1S 5,000
Al Saad Rural 4,002 #NAME? 1,247 None 998 1S 5,000
Al Araad Rural 3,962 #NAME? 1,235 None 38 1S 4,000
Abu Samra Rural 2,030 #NAME? 633 None 470 2,500
Al Ain City Urban 358,472 #NAME? 111,744 186 7 148 1,733 2,864 318 968 4.3 4.8 8.0 348,828 3 8 2M 2 707,300
Al Quaa Rural 13,076 #NAME? 4,076 1 1 8 13 1 3 0.8 0.6 1.0 9,924 1M 1 23,000
Al Wagan Rural 12,400 #NAME? 3,865 1 1 17 29 1 4 0.8 1.4 2.3 17,600 1S 1 30,000
Al Hayer Rural 12,002 #NAME? 3,741 3 3 25 34 4 3 2.5 2.1 2.8 19,998 1M 1 1 32,000
Al Dhaher Rural 11,121 #NAME? 3,467 1 1 13 20 3 4 0.9 1.2 1.8 3,229 1M 1 14,350
Remah Rural 8,556 #NAME? 2,667 1 1 6 9 2 1.2 0.7 1.1 944 1S 9,500
Sweihan Rural 8,235 #NAME? 2,567 1 1 8 11 1 1 1.2 1.0 1.3 31,765 1L 1 1 40,000
Al Khazna Rural 7,682 #NAME? 2,395 2 2 4 13 1 2.6 0.5 1.7 1,318 1S 9,000
Mezyad Rural 6,696 #NAME? 2,087 None 1 1,704 1S 8,400
Al Shwaib Rural 3,407 #NAME? 1,062 1 1 3 4 2.9 0.9 1.2 2,093 1S 5,500
Al Fagah Rural 2,183 #NAME? 681 1 1 3 3 4.6 1.4 1.4 1,317 3,500
Western Liwa Rural 41,256 #NAME? 5,803 5 1 1 8 17 5 32 0.5 0.2 0.4 23,744 1L 1 65,000
Madinat Zayed Rural 59,821 #NAME? 8,414 16 2 11 175 256 23 107 2.2 2.9 4.3 (19,821) 1 1L 1 40,000
Ruwais Rural 33,005 #NAME? 4,642 4 1 3 50 100 7 14 1.2 1.5 3.0 96,995 1 1L 1 130,000
Mirfa Rural 30,942 #NAME? 4,352 4 1 3 32 61 3 17 1.3 1.0 2.0 44,058 1L 1 75,000
Ghayathi Rural 16,502 #NAME? 2,321 6 1 5 38 63 5 18 3.6 2.3 3.8 (1,502) 1 15,000
Sila'a Rural 10,314 #NAME? 1,451 1 1 22 39 2 10 1.0 2.1 3.8 59,686 1L 1 70,000
Delma Island Rural 10,314 #NAME? 1,451 1 1 23 25 2 10 1.0 2.2 2.4 (314) 1 10,000
Capacity Gap
Severe
Moderate
None
Supply
Underserved
Potential
over supply
Gaps
Duplications
Results live capacity by location
Notes Performance is not shown for all categories of healthcare professionals or healthcare facilities. Rates shown are rates within breakdown category.
DM Clinician Category encounter numbers based on activity count ratios during sample period.
Indicator definitions are available at www.haad.ae/Datadictionary.
Source KEH Episodes with Encounter start date 1 January – 31 December 2010 as at 10 May 2011.
Drug/Diagnosis/CPT alerts: KEH, Greenrain (Sample of 3,057,800 encounters with transaction dates 1 - 30 September 2010), Dimensions Healthcare (Ingenix and CMP Medica) sample of 6,778,887 encounters with activity start dates 1 March - 10 September 2010. 29
Results clinical performance
Consultant Specialist GP Hospital Center Polyclinic Clinic Public Private
Episodes w Common Cold w Antibiotics 34 % 35 % 34 % 34 % 36 % 24 % 50 % 28 % 22 % 39 %
Routine dental extraction w complication 1 % 0 % 1 % 1 % 1 % 1 % 1 % 1 % 1 % 1 %
Episodes Obese w Lifestyle or Drugs 5 % 22 % 3 % 2 % 5 % 12 % 8 % 10 % 1 %
Episodes [GR]/Encounters [DM] w potentially
severe or life threatening drug-drug interactions
GR
DM
0.42%
0.17%1.44%
0.17%
0.61%
0.18%
0.19%
0.11%
0.60%
0.20%
0.19
%
0.09
0.00%
0.15%
0.00%
0.80%
0.82%
0.08%
0.34%
0.23%
Encounters w absolute drug-disease
interactions
DM 0.73 % 1.00% 0.74% 0.55% 0.84% 0.51% 1.20% 1.61% 0.46% 0.91%
Episodes w duplicate generic drug prescribed GR 16 % 27% 14% 19% 22% 20% 0.20% 0.17% 19% 17%
Encounters w diagnosis error alerts DM 1.52 % 1.16% 1.87% 1.08% 1.78% 1.26
%
0.89% 0.65% 0.54% 2.50%
Encounters w inappropriate CPT alerts DM 51 % 63% 51% 41% 66% 30% 21% 47% 44% 49%
© Health Authority Abu Dhabi 2009 30
Pay for Quality and Pay for Health
• Based on compliance with evidence-based care pathways and clinical quality indicators
• Mechanism set-out in Standard Contract (between Healthcare Facilities and Health Insurers)
• Expectation it will affect base payment by <10%
• “Compliance with high quality care receives a bonus”
Pay for Quality
Pay for Health
• Based on individual health status
• Health initially defined as 10-year risk of cardiovascular event (heart attack or stroke)
• Contract between individual and Disease Management Programme
• AED1,000 per 1% reduction in risk to maximum of AED5,000 (5%)
• “No health improvement – no money”
© Health Authority Abu Dhabi 2009 31
Diabetes 35,000
Pre-diabetes 55,000
Other CVD risk factors 45,000
No current CVD risk factors 55,000
3 DMPs each with multiple services Se
rvic
e 1
Serv
ice
2
Serv
ice
3
Serv
ice
1
Serv
ice
2
Serv
ice
3
Serv
ice
1
Serv
ice
2
Serv
ice
3
“Community” of 9-12 services
experimenting with different messaging
and channel mix
DMP 2 DMP 3 DMP 1
Shared data platform means HAAD can audit effectiveness real-time
DMP RoI is locked-in by design
DMP saves two Dirhams for each Dirham spent (in addition to driving innovation and saving
more than 3,000 Emirati lives)
32
Complication
Baseline 10 year
CVD risk
Annual cost of
complication
(US$)
Annual cost of CVD
in AD (AED)
Contingent annual
fiscal liability of
CVD complications
per average
Emirati
CVD risk if the
patient enrolls
in DMP
Contingent annual
fiscal liability of
CVD complications
per average
Emirati
Annual cost
saving per
patient
Cardiovascular diseases
(MI, CVA, CCF)20% $ 69,911 256,573AED AED 51,315 19% AED 48,749 AED 2,566
In-year savings based on 1% risk reduction (AED1,000) for average Emirati with diabetes
Results coding allows us to work differently
•Understanding what is happening, without relying exclusively on interviews/word of mouth Strategy
Health System Financing
Health System Compliance
Health Regulation
Health Regulation
•Alter incentives •Introduce Pay for Quality and Pay for Health
•Monitor ongoing health status with Weqaya
•Audit clinical practice/outcomes, not inputs/buildings
•Shift weight of licensure to recognising what clinicians are actually doing
33
Solution architecture offers free basic services combined with maximum innovation
•Exposes an index of web services and applications •Hosts core web services, developed by HAAD for free, including
upload, download, and access to KEH*
* Access to KEH data is being developed by Netcetera as part of the Weqaya contract
Shafafiya.org
KEH •KEH keeps a copy of all transactions exchanged on shafafiya.org
to create an electronic health record •KEH provides data access (multiple uses)
Applications
•Applications provide a user interface and are based on the consumption of web services exposed on shafafiya.org
•Free market for applications and web services, which includes HAAD’s weqaya.ae as well as 3rd party applications such as eClaimExpress.com, JeT and Greenrain Connect
Applications Applications
© Health Authority – Abu Dhabi (2010)
Redefining Health Care Elizabeth Olmsted Teisberg and Michael Porter, 2006
35
• Seminal book on health care
• Key topic is defining value in healthcare and then value-based competition on results
• More data = More analytical power + Benchmarking
It is your life we are after…
36
Healthy
Cold
Cataract
Diabetes
Appendicitis
Duration Quality
Disease Treatment
Qu
alit
y
Age
Ideal Life
Impact of
Impact on Life: